Faculty profile

Michelle Hladunewich

ResearcherMedicine/NephrologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Michelle Hladunewich

Researcher

Medicine/Nephrology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
15 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2012.
Supervisor on 1 trainee award (1 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

425

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Iga Nephropathy Methylprednisolone Randomized Placebo Controlled Trial

Latest papers

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines
Canadian Journal of Kidney Health and Disease · 2026 · senior author
PREDICT Tool for Pregnancy-Associated CKD Progression.
Kidney international reports · 2026
A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy.
Kidney international · 2026

All 52 publications

Latest funding

Expanding the use of SGLT-2 inhibitor to improve cardiorenal disease
CIHR · 2023 · Supervisor
$98,750
STARS: Surveillance and Testing for Antiviral Resistance in SARS-CoV-2
CIHR · 2022 · Co-investigator
$400,000
Regional and temporal variations in incidence, prevalence and outcomes of critical illness among pregnant and post-partum women and newborns in Canada
CIHR · 2015 · Co-investigator
$46,415

All 9 grants and awards

52 publications.

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines

Jauhal A, Mustafa R, Mathew A, Girard L, Barbour S, Prasad B, Bathini L, Poyah P, Troyanov S, Samanta R

Canadian Journal of Kidney Health and Disease20261 citationsSenior author

DOI: 10.1177/20543581251409874

PREDICT Tool for Pregnancy-Associated CKD Progression.

Ralston E, Hamill M, Santhakumaran S, Hladunewich M, Smith G, Bathini L, Jeyakumar N, Garg AX, Bramham K, PREDICT Investigation Group9, RaDaR Consortium, PREDICT Investigation Group

Kidney international reports2026

DOI: 10.1016/j.ekir.2026.106636 PMID: 42438723

A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy.

Canney M, Shan S, Er L, Billot L, Han J, Wong MG, Monaghan H, Hladunewich M, Hooi LS, Jha V, Lv J, Perkovic V, Zhang H, Cattran DC, Barbour SJ, TESTING trial steering committee

Kidney international2026

DOI: 10.1016/j.kint.2025.12.024 PMID: 41571096

Impact of Baseline Kidney Function on the Rate of Progressive Kidney Disease After Pregnancy: A Population-Based Cohort Study Research Protocol

Bathini L, Jeyakumar N, Sontrop J, McArthur E, Kang Y, Luo B, Bello A, Collister D, Ahmed S, Kaul P

Canadian Journal of Kidney Health and Disease2025

DOI: 10.1177/20543581251318836

Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy.

Gladstone RA, Snelgrove JW, McLaughlin K, Hobson SR, Windrim RC, Melamed N, Hladunewich M, Drewlo S, Kingdom JC

Obstetric medicine2025

DOI: 10.1177/1753495x251327462 PMID: 40191640

Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort.

Tarragón B, Han H, Navarro-Torres M, Canetta P, Wooden B, Derebail VK, Glenn D, Mottl A, Massicotte-Azarniouch D, Kerlin B, Hladunewich M, Coppock G, Rheault M, Mariani LH, Bomback A

Clinical kidney journal2025

DOI: 10.1093/ckj/sfaf104 PMID: 40357500

The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy.

Kim D, Lv J, Hladunewich M, Jha V, Hooi LS, Monaghan H, Shan S, Reich HN, Barbour S, Billot L, Zhang H, Perkovic V, Wong MG, TESTING trial steering committee

Kidney international reports2024

DOI: 10.1016/j.ekir.2024.03.032 PMID: 39081761

Pregnancy-associated progression of chronic kidney disease: a study protocol for the development and validation of a clinical predictive tool (PREDICT).

Ralston E, Hladunewich M, Farmer C, Carrero JJ, PREDICT Investigation Group, Bramham K

Journal of nephrology2024

DOI: 10.1007/s40620-023-01788-5 PMID: 37989974

COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces.

Atiquzzaman M, Zheng Y, Er L, Djurdjev O, Singer J, Krajden M, Balamchi S, Thomas D, Hladunewich M, Oliver MJ, Levin A

Canadian journal of kidney health and disease2023

DOI: 10.1177/20543581231181032 PMID: 37359985

Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit.

Miller JJ, Higgins V, Melamed N, Hladunewich M, Ma L, Yip PM, Fu L

The journal of applied laboratory medicine2023

DOI: 10.1093/jalm/jfad003 PMID: 36869760

Something wrong or missing on this profile? Suggest a correction

Michelle Hladunewich

Research

Latest papers

Latest funding

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines

PREDICT Tool for Pregnancy-Associated CKD Progression.

A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy.

Impact of Baseline Kidney Function on the Rate of Progressive Kidney Disease After Pregnancy: A Population-Based Cohort Study Research Protocol

Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy.

Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort.

The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy.

Pregnancy-associated progression of chronic kidney disease: a study protocol for the development and validation of a clinical predictive tool (PREDICT).

COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces.

Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit.

Frequent collaborators

Heather Reich

Nir Melamed

Daniel Cattran

Sean Barbour

Adeera Levin

Ron Wald

Amit Garg

Moumita Barua

Ayodele Odutayo

Michael Walsh

Peter Blake

Mel Krajden

Ruxandra Pinto

Kazuyoshi Aoyama

Jeffrey Perl

Stephen Lapinsky

Michael Zappitelli

Jon Barrett

Allison Dart

Ziv Harel

Reem Adel Mustafa

Atul Humar

David Klein

John Muscedere

Karen Burns

Sanjay Pandeya

David Collister

John Kingdom

York Pei

Ron Wald

Elizabeth Mccay

Jessica Sontrop

Rohan D'Souza

Rahul Chanchlani

Jenna Evans